Frontier Bio
Frontier Bio creates lab-grown human tissues to reduce the worldwide organ shortage. Their first clinical product is a tissue-engineered vascular graft made from the patient's own cells.
Industries
Nr. of Employees
small (1-50)
Frontier Bio
Frontier Bio is currently seeking investment
Frontier Bio is seeking a seed investment in the range of 1m-5m
Products
3D-bioprinted lung microtissue
Distal lung microtissue produced by 3D bioprinting combined with stem cell self-assembly, containing bronchioles, alveolar structures, vasculature, and functional features such as cilia, mucus, and surfactant.
Microfluidic blood–brain barrier chip
Organ-on-chip BBB platform that supports continuous barrier formation and neurovascular unit assembly for studies of transport, toxicity, and disease mechanisms.
Vascularized neural spheroids
Three-dimensional neural spheroids with integrated vasculature to improve nutrient/oxygen delivery and enhance functional readouts for screening and modeling.
Tissue-engineered blood vessels and aneurysm models
Living blood vessel constructs created by seeding cells onto biodegradable scaffolds and matured under biomimetic conditions; models include pathological geometries such as aneurysms for device testing.
Synthetic vascular simulation models (mechanical vessel mimics)
Non-living vessel simulants with mechanical and handling characteristics similar to native vessels for preclinical development and surgical rehearsal.
3D-bioprinted lung microtissue
Distal lung microtissue produced by 3D bioprinting combined with stem cell self-assembly, containing bronchioles, alveolar structures, vasculature, and functional features such as cilia, mucus, and surfactant.
Microfluidic blood–brain barrier chip
Organ-on-chip BBB platform that supports continuous barrier formation and neurovascular unit assembly for studies of transport, toxicity, and disease mechanisms.
Vascularized neural spheroids
Three-dimensional neural spheroids with integrated vasculature to improve nutrient/oxygen delivery and enhance functional readouts for screening and modeling.
Tissue-engineered blood vessels and aneurysm models
Living blood vessel constructs created by seeding cells onto biodegradable scaffolds and matured under biomimetic conditions; models include pathological geometries such as aneurysms for device testing.
Synthetic vascular simulation models (mechanical vessel mimics)
Non-living vessel simulants with mechanical and handling characteristics similar to native vessels for preclinical development and surgical rehearsal.
Expertise Areas
- Tissue engineering
- 3D bioprinting
- Organ-on-chip (blood–brain barrier) modeling
- Vascular tissue engineering
Key Technologies
- 3D bioprinting
- Stem cell differentiation and self-assembly
- Microfluidics (organ-on-chip)
- Biodegradable polymer scaffolds
Key People
News & Updates
Frontier Bio was nominated for the 3D Printing Industry Awards 2024, recognizing its leadership in additive manufacturing and innovation in 3D bioprinting.
Frontier Bio announced a groundbreaking achievement in lab-grown lung tissue, paving the way for advancements in treating respiratory diseases and organ transplantation.
Frontier Bio unveiled a transformative method to fabricate living human blood vessels, aiming to replace animal testing in medical device testing.
Frontier Bio was nominated for the 3D Printing Industry Awards 2024, recognizing its leadership in additive manufacturing and innovation in 3D bioprinting.
Frontier Bio announced a groundbreaking achievement in lab-grown lung tissue, paving the way for advancements in treating respiratory diseases and organ transplantation.
Frontier Bio unveiled a transformative method to fabricate living human blood vessels, aiming to replace animal testing in medical device testing.